NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 878 filers reported holding NOVARTIS A G in Q2 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $420,000 | +13.8% | 5,099 | 0.0% | 0.12% | +11.1% |
| Q1 2016 | $369,000 | -15.9% | 5,099 | -0.3% | 0.11% | -11.5% |
| Q4 2015 | $439,000 | -6.4% | 5,112 | +0.3% | 0.12% | -0.8% |
| Q3 2015 | $469,000 | -10.8% | 5,099 | -4.7% | 0.12% | +4.2% |
| Q2 2015 | $526,000 | +4.6% | 5,349 | +4.9% | 0.12% | +6.3% |
| Q1 2015 | $503,000 | +4.8% | 5,099 | -1.5% | 0.11% | +7.8% |
| Q4 2014 | $480,000 | -3.2% | 5,178 | -1.9% | 0.10% | -1.9% |
| Q3 2014 | $496,000 | +7.1% | 5,277 | +3.1% | 0.10% | +9.4% |
| Q2 2014 | $463,000 | +3.8% | 5,119 | -2.5% | 0.10% | +7.9% |
| Q1 2014 | $446,000 | +3.5% | 5,250 | -1.9% | 0.09% | +7.2% |
| Q4 2013 | $431,000 | +4.9% | 5,350 | 0.0% | 0.08% | -5.7% |
| Q3 2013 | $411,000 | +26.5% | 5,350 | +16.5% | 0.09% | +29.4% |
| Q2 2013 | $325,000 | – | 4,593 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |